Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-77https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Immunother. 2006 Jan-Feb;29(1):67-772006-01-01 00:00:002006-01-01 00:00:00Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Surg. Today 2006;36(6):559-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Surg. Today 2006;36(6):559-622006-01-01 00:00:002019-02-15 08:36:22Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-102006-01-01 00:00:002019-02-15 08:37:43Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-01-01 / Cytotherapy 2006;8(4):318-26https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-01-01 / Cytotherapy 2006;8(4):318-262006-01-01 00:00:002019-02-15 08:45:56Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-21https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-212005-12-01 00:00:002019-02-15 09:00:03Harnessing the immune system against human glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-12-01 / Int J Hyperthermia 2005 Dec;21(8):723-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-12-01 / Int J Hyperthermia 2005 Dec;21(8):723-92005-12-01 00:00:002019-02-15 09:17:45Thermal regulation of lymphocyte trafficking: hot spots of the immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-46https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-462005-11-29 00:00:002019-02-15 09:19:48Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-62005-11-26 00:00:002019-02-15 09:19:50Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-95https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-952005-11-20 00:00:002019-02-15 08:38:52Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-82005-11-15 00:00:002005-11-15 00:00:00Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-62005-11-14 00:00:002019-02-15 09:11:49Immunological treatment of liver tumors
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
Genetically modified dendritic cells for therapeutic immunity
Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell–associated antigens
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells
Harnessing the immune system against human glioma
Thermal regulation of lymphocyte trafficking: hot spots of the immune response
Virus-based therapies for colon cancer
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
Vaccine strategies to treat lymphoproliferative disorders
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
Immunological treatment of liver tumors
Prostate cancer immunology: biology, therapeutics, and challenges
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection